Orphan Drug Act

Results: 190



#Item
81August 6, 2013 The Honorable Patrick J. Toomey 248 Russell Senate Office Building Washington, DC[removed]Dear Senator Toomey: On behalf of the 30 million men, women and children in the U.S. affected by the estimated 7,300

August 6, 2013 The Honorable Patrick J. Toomey 248 Russell Senate Office Building Washington, DC[removed]Dear Senator Toomey: On behalf of the 30 million men, women and children in the U.S. affected by the estimated 7,300

Add to Reading List

Source URL: www.rarediseases.org

Language: English - Date: 2013-09-26 15:14:25
82August 6, 2013 The Honorable Jim Gerlach 2442 Rayburn House Office Building Washington, DC[removed]Dear Mr. Gerlach: On behalf of the 30 million men, women and children in the U.S. affected by the estimated 7,300 known rar

August 6, 2013 The Honorable Jim Gerlach 2442 Rayburn House Office Building Washington, DC[removed]Dear Mr. Gerlach: On behalf of the 30 million men, women and children in the U.S. affected by the estimated 7,300 known rar

Add to Reading List

Source URL: www.rarediseases.org

Language: English - Date: 2013-09-26 15:15:11
83Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders by Frank J. Sasinowski, M.S., M.P.H., J.D.1 Chairman of the Bo

Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders by Frank J. Sasinowski, M.S., M.P.H., J.D.1 Chairman of the Bo

Add to Reading List

Source URL: nordphysicianguides.org

Language: English - Date: 2013-06-21 13:23:45
84Prospects for Rapid Advances in the Development of New Medicines for Special Medical Needs

Prospects for Rapid Advances in the Development of New Medicines for Special Medical Needs

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2014-02-03 14:11:10
85

PDF Document

Add to Reading List

Source URL: www.hrsa.gov

Language: English - Date: 2012-10-04 17:58:42
86Case 1:13-cv[removed]RC Document 1 Filed[removed]Page 1 of 16  UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ) PHARMACEUTICAL RESEARCH AND

Case 1:13-cv[removed]RC Document 1 Filed[removed]Page 1 of 16 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ) PHARMACEUTICAL RESEARCH AND

Add to Reading List

Source URL: www.thecre.com

Language: English - Date: 2014-08-05 06:47:44
87ION_logowallpap_8321_CMYK

ION_logowallpap_8321_CMYK

Add to Reading List

Source URL: www.fda.gov

Language: English
88Case 1:13-cv[removed]RC Document 43 Filed[removed]Page 1 of 30  UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,

Case 1:13-cv[removed]RC Document 43 Filed[removed]Page 1 of 30 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,

Add to Reading List

Source URL: www.thecre.com

Language: English - Date: 2014-08-05 06:48:50
89ARNALL GOLDEN & GREGORY,LLP A PARTNERSHIP INCLUDING  2800

ARNALL GOLDEN & GREGORY,LLP A PARTNERSHIP INCLUDING 2800

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 1998-10-28 11:19:28
90Orphan Drug Analysis[removed]xlsx

Orphan Drug Analysis[removed]xlsx

Add to Reading List

Source URL: info.evaluategroup.com

Language: English - Date: 2014-10-17 14:06:35